Skip to main content
SpringerLink
Log in

HRT increases likelihood of venous thromboembolism, but overall risk small

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Committee on Safety of Medicines, Medicines Control Agency. Risk of venous thromboembolism with hormone replacement therapy. Curr Probl Pharmacovigilance 1996; 22: 9–10

    Google Scholar 

  2. Castellsague J, Pérez Gutthann S, García Rodríguez LA. Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism: a review. Drug Saf 1998 Feb; 18(2): 117–23

    Article  PubMed  CAS  Google Scholar 

  3. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Surgically confirmed gallbladder, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. N Engl J Med 1974; 290: 15–9

    Article  Google Scholar 

  4. Daly E, Vessey MP, Hawkins MM, et al. Case-control study of venous thromboembolism disease and use of hormone replacement therapy. Lancet 1996; 348: 977–80

    Article  PubMed  CAS  Google Scholar 

  5. Jick H, Derby L. The risk of hospitalization for idiopathic venous thromboembolism among users of postmenopausal estrogens. Lancet 1996; 348: 981–3

    Article  PubMed  CAS  Google Scholar 

  6. Pérez-Gutthann S, García-Rodríguez LA, Castellsague J, et al. Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. BMJ 1997; 314: 796–800

    Article  PubMed  Google Scholar 

  7. Varas C, García-Rodríguez LA, Cattaruzzi C, et al. Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe. Am J Epidemiol 1998 Feb 15; 147(4): 387–90

    Article  Google Scholar 

  8. Grodstein F, Stampfer MJ, Goldhaber SZ, et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 1996; 348: 983–7

    Article  PubMed  CAS  Google Scholar 

  9. Vandenbroucke JP, Koster T, Briet E, et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1454–7

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

HRT increases likelihood of venous thromboembolism, but overall risk small. Drugs Ther. Perspect 12, 14–16 (1998). https://doi.org/10.2165/00042310-199812060-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199812060-00004

Keywords

Search

Navigation